Therapeutic Approaches & Targets for Viral Infections
The Americas commanded the largest share 42% of the Global Microbiology Market at an estimated $1485.02 million in 2013 and are expected to reach $1932.8 million by 2018, at a CAGR of 5.6% from 2013 to 2018.
DNA immunization is a novel method used to efficiently fortify humoral and cellular immune responses to protein antigens. Viral vaccines contain either inactivated viruses or constricted viruses .Inactive viral vaccines contain a virus, which have lost their ability to replicate and in order for it to bring about a response it contains more antigen than live immunizations. Allergy immunotherapy is a clinically documented efficacious treatment, which may considerably reduce the patient’s allergic symptoms and the need for traditional, symptom-relieving medication. Antiviral drugs are a class of medication utilized particularly for treating viral contaminations.
- Oncolytic virotherapy
- Viral immunotherapy
- DNA Immunization
- Antigen presenting cell-targeted therapy
- Antiviral drugs and adjuvants
Related Conference of Therapeutic Approaches & Targets for Viral Infections
10th International Congress on Trauma, Critical Care and Emergency Medicine
19th International Conference on Virology, Emerging Diseases & vaccines
9th International Conference on Molecular Medicine and Diagnostics
8th International Conference on Microbiome, Probiotics & Gut Nutrition
7th International Conference on Antimicrobial and Antibacterial Agents
7th International Conference on Clinical Microbiology, Virology and Infectious Diseases
Therapeutic Approaches & Targets for Viral Infections Conference Speakers
Recommended Sessions
- Agriculture and plant virology
- Clinical & Neuro Virology
- Current Focus in Virology Research
- Drug discovery program
- HIV & Other Emerging Viruses affecting Afro-Asian Continents
- Host Immune Defences & Immunotherapy
- Pediatric Viral Diseases
- Recent Advances in Viral Therapy
- Therapeutic Approaches & Targets for Viral Infections
- Tumour Virology and Immunology
- Vaccines and Viral Vectors
- Veterinary Virology
- Viral Evolution & General Virology
- Viral hepatitis
Related Journals
Are you interested in
- 16S sequencing & Analysis - Microbiome 2024 (UK)
- Agriculture Microbiology - Beneficial Microbes 2024 (Ireland)
- Animals in a bacterial world, a new imperative for the life sciences - Microbiome 2024 (UK)
- Antimicrobial Use in Veterinary Medicine - Antimicrobial Congress 2024 (Czech Republic)
- Antimicrobials - Antimicrobial Congress 2024 (Czech Republic)
- Antiviral Therapies and Drug Development - Antimicrobial Congress 2024 (Czech Republic)
- Arbuscular Mycorrhizal Fungi [AMF] - Microbiome 2024 (UK)
- Beneficial Microbes in the environment - Beneficial Microbes 2024 (Ireland)
- Benefits Of Bio stimulants - Microbiome 2024 (UK)
- Bioinformatics for Microbiome - Microbiome 2024 (UK)
- Biological Need of Trauma - TRAUMA 2024 (Netherlands)
- Biostimulants and Biocontrol strategies - Microbiome 2024 (UK)
- Blunt Trauma - TRAUMA 2024 (Netherlands)
- Clinical and Neuro Virology - Virology-2024 (Canada)
- Combination Therapy for Antimicrobial Resistance - Antimicrobial Congress 2024 (Czech Republic)
- Corona Virus - Virology-2024 (Canada)
- Critical Care in Trauma - TRAUMA 2024 (Netherlands)
- Delirium in Critical Care - TRAUMA 2024 (Netherlands)
- Drug-Resistant Bacteria: Challenges and Solutions - Antimicrobial Congress 2024 (Czech Republic)
- Ecology and Evolution of Microbe-Host Interactions - Beneficial Microbes 2024 (Ireland)
- Elderly Trauma and Critical Care - TRAUMA 2024 (Netherlands)
- Engineering Beneficial Microbes - Beneficial Microbes 2024 (Ireland)
- Evolution in Emergency Medicine Practices - TRAUMA 2024 (Netherlands)
- General Virology - Virology-2024 (Canada)
- Gut Micro biota - Microbiome 2024 (UK)
- Harnessing phyto Microbiome signaling for Microbiome engineering - Microbiome 2024 (UK)
- Harnessing phyto Microbiome signaling for Microbiome engineering - Microbiome 2024 (UK)
- HIV/AIDS and Sexually Transmitted Infections - Virology-2024 (Canada)
- Horticulture Hydroponics - Microbiome 2024 (UK)
- Host-Microbe Biology (HMB) - Microbiome 2024 (UK)
- Human Micro biota - Microbiome 2024 (UK)
- Immunization and Immunotherapeutics - Virology-2024 (Canada)
- Immunobiotics - Beneficial Microbes 2024 (Ireland)
- Influenza and other Respiratory Diseases - Virology-2024 (Canada)
- Intensive Care in Trauma - TRAUMA 2024 (Netherlands)
- Interplay between diet, gut micro biota, epigenetic events, and colorectal cancer - Microbiome 2024 (UK)
- Marine Microbiology - Beneficial Microbes 2024 (Ireland)
- Mechanisms of Antibiotic Resistance - Antimicrobial Congress 2024 (Czech Republic)
- Micro biota in early life shapes the immune system - Microbiome 2024 (UK)
- Microbial Infections - Virology-2024 (Canada)
- Microbiome - Beneficial Microbes 2024 (Ireland)
- Microbiome - Microbiome 2024 (UK)
- Microbiome as a human organ - Microbiome 2024 (UK)
- Microbiome: Science comes to life - Microbiome 2024 (UK)
- Modulation of Micro biota - Microbiome 2024 (UK)
- Nanotechnology in Antimicrobial Drug Delivery - Antimicrobial Congress 2024 (Czech Republic)
- New and Endogenous Retroviruses - Virology-2024 (Canada)
- New Technology in Trauma - TRAUMA 2024 (Netherlands)
- Novel Antibiotics and Antimicrobial Agents - Antimicrobial Congress 2024 (Czech Republic)
- Novel Antiviral Therapies - Virology-2024 (Canada)
- Novel Vaccine Delivery Methods - Virology-2024 (Canada)
- Obstetric Trauma - TRAUMA 2024 (Netherlands)
- Paediatric Trauma - TRAUMA 2024 (Netherlands)
- Pathogenic Microbes in Immunology and Microbiology - Beneficial Microbes 2024 (Ireland)
- Pathogenic Microbes in Medicine and Dentistry - Beneficial Microbes 2024 (Ireland)
- Pediatric Microbiome [Vaginal Delivery Versus C-Section] - Microbiome 2024 (UK)
- Pharmacogenomics - Microbiome 2024 (UK)
- Pharmacokinetics and Pharmacodynamics of Antimicrobials - Antimicrobial Congress 2024 (Czech Republic)
- Plant Beneficial Microbes - Microbiome 2024 (UK)
- Plant Conditioners [Biostimulants] - Microbiome 2024 (UK)
- Prebiotics and Probiotics - Microbiome 2024 (UK)
- Probiotics & Prebiotics - Beneficial Microbes 2024 (Ireland)
- Psychological Trauma - TRAUMA 2024 (Netherlands)
- Role of microbial communities in the pathogenesis of periodontal diseases and caries (Oral Microbiome) - Microbiome 2024 (UK)
- Signaling in the phytoMicrobiome - Microbiome 2024 (UK)
- Skincare products with probiotics worth the hype - Microbiome 2024 (UK)
- Soil biological management - Beneficial Microbes 2024 (Ireland)
- Strategies for Fungal Infections - Antimicrobial Congress 2024 (Czech Republic)
- Structural and Molecular virology - Virology-2024 (Canada)
- The Dynamic Microbiome - Microbiome 2024 (UK)
- The globalization of cannabis cultivation- A Growing Challenge - Microbiome 2024 (UK)
- The Microbiome as a Therapeutic Target for Metabolic Diseases - Microbiome 2024 (UK)
- The role of the Microbiome in cancer development and therapy - Microbiome 2024 (UK)
- The Skin Microbiome - Microbiome 2024 (UK)
- Transmission of Viruses - Virology-2024 (Canada)
- Transplant-Associated Viral Infections - Virology-2024 (Canada)
- Trauma & Critical Care Nursing - TRAUMA 2024 (Netherlands)
- Trauma Emergency Medicine - TRAUMA 2024 (Netherlands)
- Trauma in Nursing & Midwifery - TRAUMA 2024 (Netherlands)
- Trauma Therapy - TRAUMA 2024 (Netherlands)
- Trauma-An International Perspective - TRAUMA 2024 (Netherlands)
- Trauma-Mass Casualties Incidents - TRAUMA 2024 (Netherlands)
- Vaccines against Emerging Diseases (Ebola/Zika/Dengue/Chik) - Virology-2024 (Canada)
- Vaccines and Immunotherapies - Antimicrobial Congress 2024 (Czech Republic)
- Vaccines and the Microbiome - Virology-2024 (Canada)
- Veterinary virology - Virology-2024 (Canada)
- Viral Genetics, Evolution and Dynamics - Virology-2024 (Canada)
- Viral Immunology and Immunopathology - Virology-2024 (Canada)
- Viral Oncology - Virology-2024 (Canada)
- Viral Pathogenesis - Virology-2024 (Canada)